EDGAR Filing Documents for 0001213900-16-019159

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

SEC Accession No. 0001213900-16-019159

Filing Date

2016-12-06

Accepted

2016-12-05 19:29:25

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 2 TO FORM F-1	ff12016a2_therapixbio.htm	F-1/A	3525514
2	LICENSE AGREEMENT DATED MAY 20, 2015, BY AND BETWEEN THE COMPANY AND DEKEL PHARM	ff12016a2ex10i_therapix.htm	EX-10.1	108716
3	CONSENT OF KOST FORER GABBAY & KASIERER (A MEMBER OF EY GLOBAL).	ff12016a2ex23i_therapix.htm	EX-23.1	2984
4	GRAPHIC	image_001i.jpg	GRAPHIC	6476
5	GRAPHIC	image_004.jpg	GRAPHIC	21294
6	GRAPHIC	image_002.jpg	GRAPHIC	3163
7	GRAPHIC	logorod_001.jpg	GRAPHIC	3731
	Complete submission text file	0001213900-16-019159.txt		3686543

Mailing Address SCIENCE PARK, 18 EINSTIEN ST. P.O BOX 4122 NESS-ZIONA L3 7414002

Business Address SCIENCE PARK, 18 EINSTIEN ST. P.O BOX 4122 NESS-ZIONA L3 7414002 972-8-9396577

Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)